Announcements Trials

Browse Landscape

Phase

Status

Recruiting 26 Active not recruiting 20 Not yet recruiting 5 Completed 4 Terminated 3 Suspended 1 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Interventions

Standard of Care 2 Practice Guidelines as Topic 2 Methods 2 Interviews as Topic 2 Educational Status 2 Early Intervention, Educational 2 Counseling 2 sacituzumab govitecan 1 pembrolizumab 1 ibrutinib 1 futibatinib 1 erdafitinib 1 enfortumab vedotin 1 durvalumab 1 avelumab 1 Vinblastine 1 Tramadol 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Specimen Handling 1 Robotic Surgical Procedures 1 Relaxation Therapy 1 Radiotherapy, Adjuvant 1 Pregabalin 1 Platinum Compounds 1 Photochemotherapy 1 Patient Navigation 1 Palliative Care 1 Paclitaxel 1 Nivolumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Enrolling by invitation × durvalumab × 30 days × Clear all

NCT05303532 2026-05-19

ROSY-D

AstraZeneca

Phase 3 Enrolling by invitation

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡